Matthew G. Clark | Joint Project Manager, CBRN Medical
JPEO-CBRND

Matthew G. Clark, Joint Project Manager, CBRN Medical, JPEO-CBRND

Colonel Matthew G. Clark is the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical). He is responsible for leading the
medical portfolio for the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). COL Clark previously served as Senior Policy Advisor and Director of COVID-19 International Response Operations on the White House COVID-19 Response Team
(WHCRT), after serving as the Lead Program Manager for the vaccine team in Operation Warp Speed. He was on hiatus from serving as the Director of the Office of Medical
Systems under the Assistant Secretary of the Army for Acquisition, Logistics, and Technology. On the WHCRT, he led operations to move 1.2+ billion COVID-19 vaccines
to 115 countries bilaterally and through: COVID-19 Vaccines Global Access, involving Gavi (The Vaccine Alliance); theWorld Health Organization; the United Nations Children's Fund; the Pan American Health Organization global organizations; and the African Vaccine Acquisition Trust, via the African Union. He worked the whole-of-government vaccine response through: the U.S. Department of Health and Human Services Coordination Operation Response Element (formerly the Countermeasures Acceleration Group); the Departments of State and Defense; the U.S. Agency for International Development; the National Institutes of Health; the U.S. Food and Drug Administration; the Centers for Disease Control and Prevention; and the Federal Emergency Management Agency. The public-private team he led delivered over 534 million doses.  COL Clark previously served as Joint Product Manager for Chemical Defense Pharmaceuticals in the JPEO-CBRND. His team received a Gold-level Edison Award™ of
Innovation for high-quality, rapid product development for tightly-engineered capabilities, published in four Army AL&T Magazine articles; and received MG Harry Greene Awards
in 2018 and 2019. He was also the first medical officer recognized as the U.S. Army’s Product Manager of the Year in 2018. In other leadership positions around the world, he
directed medical clinics and laboratories, served as Military Legislative Assistant in the U.S. House of Representatives, and as the Director of the Eisenhower Leader Development Program at the U.S. Military Academy at West Point and Columbia University. He is a distinguished graduate of Coe College and received a PhD in behavioral and neural sciences from Rutgers University. He also has a master’s with distinction in strategic studies from the Army War College, and in 2021, received a doctorate of humane letters from Coe College. He has published two edited books, eight book chapters, and over 30 peer-reviewed and professional articles.

Appearances:



Pre-Congress Workshops - 21st April @ 10:00

BIODEFENSE

Protecting public health from biothreats to pandemics.

 

  • What is the progress on new technologies in medical product development?
  • How our governments are incentivizing (portfolio approach), especially with biotech and industry? What International collaborations are being facilitated?

10:10 – 10:50 Coupled lightening talks: ~10 minutes each

How our governments are incentivizing (portfolio approach), especially with biotech and industry?

10:55 – 11:50 Panel: Collaboration with industry: the solution for a sustainable posture for biodefence and global health security

11:50 – 12:50 Panel: Rapid vaccine development through manufacturing innovation 

1:00 - 2:00 break

2:00 – 3:10 Panel: What are the remaining bottlenecks holding us back from achieving the 100 day mission?

3:10 – 4:10 Panel: International pandemic funding – how can we make it accessible globally?

4:10 – 5:00 Recap Panel: What are the drivers between different international governments and how can we harmonize these to strengthen our defense from global biothreats?

 

Session led by: ati---advanced-technology-international
Session led by: lumacyte

Main Congress Day 3 - 24th April @ 09:10

Panel: What kind of partnership mechanisms are necessary to form better strategic collaborations between academic institutes, research institutes, government, biotech and pharma?

last published: 13/Mar/25 11:25 GMT

back to speakers